StockMacro
Company, fund or insider

Help

Menu

Actuate Therapeutics

$0.23 -90% in 6 monthsMarket cap $13.6M

ACTU on XNAS, Health Care, Actuate Therapeutics, Inc., job postings

Measures activity, not value. Not investment advice.

Shares down 96% in a year as institutional holders fell 37% and a delisting notice arrived.

  • BadThree share registrations (S-1) filed in 90 days, adding shares
  • WatchCompanies filing S-1s trailed their sector by 23.8 points over 6 months

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3B, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.

Industry
Pharmaceutical preparations (Health Care)
Employees
12
Website
actuatetherapeutics.com
Listed
Nasdaq, US
Revenue and net income per quarter. Quarter to 30 Sep 2026: net loss $3.4M.
Quarter to 31 Mar 2023: revenue –, net income -$5.3MQuarter to 30 Jun 2023: revenue –, net income -$5.5MQuarter to 30 Sep 2023: revenue –, net income -$6.3MQuarter to 31 Dec 2023: revenue –, net income -$7.6MQuarter to 31 Mar 2024: revenue –, net income -$8.3MQuarter to 30 Jun 2024: revenue –, net income -$6.6MQuarter to 30 Sep 2024: revenue –, net income -$6.0MQuarter to 31 Dec 2024: revenue –, net income -$6.4MQuarter to 31 Mar 2025: revenue –, net income -$6.3MQuarter to 30 Jun 2025: revenue –, net income -$5.9MQuarter to 30 Sep 2025: revenue –, net income -$5.4MQuarter to 31 Dec 2025: revenue –, net income -$4.6MQuarter to 31 Mar 2026: revenue –, net income -$5.6MQuarter to 30 Jun 2026: revenue –, net income -$4.9MQuarter to 30 Sep 2026: revenue –, net income -$3.4M
31 Mar 2023RevenueNet incomeNet losstallest bar $8.3M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026–-$3.4M
30 Jun 2026–-$4.9M
31 Mar 2026–-$5.6M
31 Dec 2025–-$4.6M
30 Sep 2025–-$5.4M
30 Jun 2025–-$5.9M
31 Mar 2025–-$6.3M
31 Dec 2024–-$6.4M
30 Sep 2024–-$6.0M
30 Jun 2024–-$6.6M
31 Mar 2024–-$8.3M
31 Dec 2023–-$7.6M
30 Sep 2023–-$6.3M
30 Jun 2023–-$5.5M
31 Mar 2023–-$5.3M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. – –
Revenue growthRevenue of the last 12 months compared with the 12 months before. – +11%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$18.5M -$24.1M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). – –
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. – – 73.2%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. – – -25.0%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. – – -18.2%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. – -58.8%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. – –
CashCash, cash equivalents and short-term investments on the latest balance sheet. $2.1M $16.9M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $405K –
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). -$1.7M (net cash) –
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. – 0.0
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. –
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 19.3
P/SPrice to sales: market cap divided by revenue of the last 12 months. – 5.0
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. – 5.0
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. – 2.0

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
Actuate TherapeuticsACTU (this company) $13.6Mloss–––
BeyondSpringBYSI $13.7M––––
Citius Pharmaceuticals Inc. CommonCTXR $14.0Mloss–––
Tvardi TherapeuticsTVRD $13.2Mloss–––
Bolt BiotherapeuticsBOLT $12.8Mloss5.1-51%–
Neuphoria TherapeuticsNEUP $12.7Mloss–––

Insider buy/sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

+$50K

bought $50K, sold $0

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

-37%

41 13F filers vs 65

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

22%

13.3M shares held by 13F filers (30 Sep 2026) of 60.4M outstanding (13 Nov 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

2.2%

1.3M shares sold short (30 Oct 2026) of 60.4M outstanding (13 Nov 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

2.1

1.3M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-30%

1.9M shares sold short in the report before, 1.3M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

44%

44% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 51%

News Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

13

13 articles in the last 7 days; its usual week has 3 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

4.3×

13 articles in the last 7 days; its usual week has 3.

Unusual now sharp changes in the last 90 days, compared with its own past

  • Short interest 1.9M, 3.3× a year earlier

Price $0.23 on 20 Nov 2026, -96% over 12 months (12-month range $0.21 to $7.63)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders sold a net $1.6M in the last 12 months (the 12 months before: $500K).
Institutional holders (13F filers). 41 13F filers reported holding it in the latest 13F quarter, -4.7% on a year earlier.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, revenue per quarter, capital spending per quarter, federal obligations, lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
30 Oct 20268-K and other filingsDelisting notice or listing transfer
27 Oct 2026Sharp changeShort interest spike: short interest spike, 1.9M vs usual 661K (2026-10-15); 3.3x the same period a year earlier
19 Oct 20268-K and other filingsRegistered new securities for sale (S-1)
14 Oct 20268-K and other filingsRegistered new securities for sale (S-1)
6 Oct 20268-K and other filingsRegistered new securities for sale (S-1)
15 Sep 2026Sharp changeShort interest spike: short interest spike, 1.2M vs usual 625K (2026-08-31); 2.1x the same period a year earlier
17 Jul 20268-K and other filingsDelisting notice or listing transfer
12 May 2026Sharp changeShort interest spike: short interest spike, 948K vs usual 551K (2026-04-30); 6.9x the same period a year earlier
6 May 20268-K and other filingsDirector or officer change
6 May 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
28 Apr 2026Sharp changeShort interest spike: short interest spike, 915K vs usual 543K (2026-04-15); 7.0x the same period a year earlier
28 Oct 2025Sharp changeShort interest spike: short interest spike, 561K vs usual 115K (2025-10-15); 16.5x the same period a year earlier
14 Oct 2025Sharp changeShort interest spike: short interest spike, 615K vs usual 96K (2025-09-30); 46.6x the same period a year earlier
30 Sep 2025Sharp changeShort interest spike: short interest spike, 566K vs usual 89K (2025-09-15); 45.8x the same period a year earlier
16 Sep 2025Sharp changeShort interest spike: short interest spike, 549K vs usual 83K (2025-08-29); 72.7x the same period a year earlier
2 Sep 2025Sharp changeShort interest spike: short interest spike, 585K vs usual 81K (2025-08-15); 136.5x the same period a year earlier
25 Jul 20258-K and other filingsRegistered new securities for sale (S-1)
7 Jul 20258-K and other filingsPrivate placement of securities (Form D)
10 Apr 20258-K and other filingsPrivate placement of securities (Form D)
28 Mar 20258-K and other filingsRegistered new securities for sale (S-1)
19 Aug 20248-K and other filingsChanged its auditor
14 Aug 20248-K and other filingsDirector or officer change
14 Aug 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
23 Jul 20248-K and other filingsRegistered new securities for sale (S-1)
19 Jul 20248-K and other filingsRegistered new securities for sale (S-1)
16 Jul 20248-K and other filingsRegistered new securities for sale (S-1)
21 Jun 20248-K and other filingsRegistered new securities for sale (S-1)
11 Jun 20248-K and other filingsRegistered new securities for sale (S-1)
24 May 20248-K and other filingsRegistered new securities for sale (S-1)
6 Mar 20248-K and other filingsPrivate placement of securities (Form D)
19 Oct 20228-K and other filingsPrivate placement of securities (Form D)
Insider net buying (open market)
Month from 1 Aug 2024: $3.6M published
Month from 1 Jul 2025: $500K published
Month from 1 Jan 2026: -$1.6M published
Month from 1 Oct 2026: $50K published
Institutional holders (13F filers)
30 Sep 2024 report: 10; public on 14 Nov 2024
31 Dec 2024 report: 19; public on 14 Feb 2025
31 Mar 2025 report: 25; public on 15 May 2025
30 Jun 2025 report: 35; public on 14 Aug 2025
30 Sep 2025 report: 43; public on 14 Nov 2025
31 Dec 2025 report: 45; public on 17 Feb 2026
31 Mar 2026 report: 59; public on 15 May 2026
30 Jun 2026 report: 65; public on 14 Aug 2026
30 Sep 2026 report: 41; public on 16 Nov 2026

What is unusual now

  • Made public in the last 90 days: it had 1.9M shares sold short in the 15 Oct 2026 report, 3.3× the same report last year; it also had 1.2M shares sold short in the 31 Aug 2026 report, 2.1× the same report last year.
  • Short interest spike: had 1.9M shares sold short in the 15 Oct 2026 report, 3.3× the same report last year Public on 27 Oct 2026.
  • Insider net buying (open market): Insiders sold a net $1.6M in the last 12 months (the 12 months before: $500K).
  • Institutional holders (13F filers): 41 13F filers reported holding it in the latest 13F quarter, -4.7% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 15 insider trades

Last 90 days: no sales; 1 purchase, $50K. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
29 Oct 2026Daniel M SchmittPresident, CEO and DirectorBuy140,844$0.36$50KForm 4
7 Jan 2026Todd S Thomson and 1 otherDirector, 10% ownerSell280,000$5.80$1.6MForm 4
30 Jun 2025BIOS Actuate Co-Invest I, LP and 9 othersDirector, 10% ownerBuy71,428$7.00$500KForm 4
16 Aug 2024Kairos-Actuate SPV, L.P. and 4 others1.5% OwnerSell18,750$8.00$150KForm 4
14 Aug 2024BIOS Fund II QP, LP and 9 othersDirector, 10% ownerSell24,999$9.00$225KForm 4
14 Aug 2024BIOS Fund II QP, LP and 9 othersDirector, 10% ownerBuy500,000$8.00$4.0MForm 4

41 institutions reported shares at the end of Q3 2026, 22% of the shares outstanding; 3 opened a position, 25 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
BIOS Capital Management, LP10.0M16.6%$7.8MNo change
Voss Capital, LP1.9M3.15%$1.5M+174K+10%
Vanguard Capital Management LLC393K0.65%$307KNo change
Geode Capital Management, LLC104K0.17%$81K-8,239-7.3%
Texas Capital Bank Wealth Management Services Inc103K0.17%$80KNo change
Palogic Value Management, L.P.100K0.17%$78K-100K-50%
Millennium Management LLC90K0.15%$70K-6,489-6.7%
ABS Investment Management LLC73K0.12%$57KNo change
BlackRock, Inc.67K0.11%$52K-23K-26%
Vanguard Fiduciary Trust Co54K0.09%$43KNo change

Company events

All 31 company events

In 12 months: 3 share registrations, 2 major agreements, 2 delisting notices, 1 director or officer change. Results releases and routine reports are left out.

FiledWhat happenedSource
30 Oct 2026Delisting notice or listing transfer8-K
28 Oct 2026Signed a major agreement8-K
19 Oct 2026Registered new securities for sale (S-1)S-1/A
14 Oct 2026Registered new securities for sale (S-1)S-1/A
6 Oct 2026Registered new securities for sale (S-1)S-1
17 Jul 2026Delisting notice or listing transfer8-K
6 May 2026Director or officer change8-K
28 Nov 2025Signed a major agreement8-K

The 5 newest of 132 articles that name the company.

Timeline
Kind of data

Timeline

Changes and notable records, by the date each became public

  1. 30 Oct 2026Filings record

    Delisting notice or listing transfer

  2. 29 Oct 2026Insiders record

    SCHMITT DANIEL M (President, CEO and Director) bought 140,844 shares of ACTU ($50,000)

  3. 27 Oct 2026Short interest and volume change

    had 1.9M shares sold short in the 15 Oct 2026 report, 3.3× the same report last year.

    Same report last year: 561K; its normal report is 661K.

    See the evidence
    This period
    1.9M (the 15 Oct 2026 report)
    Normal report (median of 24 earlier)
    661K
    Typical spread (median absolute deviation)
    174K
    How far from its usual level
    +4.7
    Same report last year
    561K
    History used
    791 days
    2025-10-15: 561K2025-10-31: 491K2025-11-14: 482K2025-11-28: 484K2025-12-15: 437K2025-12-31: 530K2026-01-15: 532K2026-01-30: 615K2026-02-13: 635K2026-02-27: 641K2026-03-13: 669K2026-03-31: 653K2026-04-15: 915K2026-04-30: 948K2026-05-15: 883K2026-05-29: 921K2026-06-15: 915K2026-06-30: 687K2026-07-15: 755K2026-07-31: 450K2026-08-14: 696K2026-08-31: 1.2M2026-09-15: 1.1M2026-09-30: 1.3M2026-10-15: 1.9M
    the 15 Oct 2026 report24 earlier reportsnormal: 661K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  4. 19 Oct 2026Filings record

    Registered new securities for sale (S-1)

  5. 14 Oct 2026Filings record

    Registered new securities for sale (S-1)

  6. 6 Oct 2026Filings record

    Registered new securities for sale (S-1)

  7. 11 Sep 2026Short interest and volume change

    had 1.2M shares sold short in the 31 Aug 2026 report, 2.1× the same report last year.

    Same report last year: 549K; its normal report is 625K.

    See the evidence
    This period
    1.2M (the 31 Aug 2026 report)
    Normal report (median of 24 earlier)
    625K
    Typical spread (median absolute deviation)
    94K
    How far from its usual level
    +3.9
    Same report last year
    549K
    History used
    746 days
    2025-08-29: 549K2025-09-15: 566K2025-09-30: 615K2025-10-15: 561K2025-10-31: 491K2025-11-14: 482K2025-11-28: 484K2025-12-15: 437K2025-12-31: 530K2026-01-15: 532K2026-01-30: 615K2026-02-13: 635K2026-02-27: 641K2026-03-13: 669K2026-03-31: 653K2026-04-15: 915K2026-04-30: 948K2026-05-15: 883K2026-05-29: 921K2026-06-15: 915K2026-06-30: 687K2026-07-15: 755K2026-07-31: 450K2026-08-14: 696K2026-08-31: 1.2M
    the 31 Aug 2026 report24 earlier reportsnormal: 625K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  8. 17 Jul 2026Filings record

    Delisting notice or listing transfer

  9. 12 May 2026Short interest and volume change

    had 948K shares sold short in the 30 Apr 2026 report, 6.9× the same report last year.

    Same report last year: 137K; its normal report is 551K.

    See the evidence
    This period
    948K (the 30 Apr 2026 report)
    Normal report (median of 24 earlier)
    551K
    Typical spread (median absolute deviation)
    66K
    How far from its usual level
    +4.1
    Same report last year
    137K
    History used
    623 days
    2025-04-30: 137K2025-05-15: 198K2025-05-30: 212K2025-06-13: 241K2025-06-30: 536K2025-07-15: 552K2025-07-31: 615K2025-08-15: 585K2025-08-29: 549K2025-09-15: 566K2025-09-30: 615K2025-10-15: 561K2025-10-31: 491K2025-11-14: 482K2025-11-28: 484K2025-12-15: 437K2025-12-31: 530K2026-01-15: 532K2026-01-30: 615K2026-02-13: 635K2026-02-27: 641K2026-03-13: 669K2026-03-31: 653K2026-04-15: 915K2026-04-30: 948K
    the 30 Apr 2026 report24 earlier reportsnormal: 551K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  10. 6 May 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  11. 6 May 2026Filings record

    Director or officer change

  12. 25 Apr 2026Short interest and volume change

    had 915K shares sold short in the 15 Apr 2026 report, 7.0× the same report last year.

    Same report last year: 130K; its normal report is 543K.

    See the evidence
    This period
    915K (the 15 Apr 2026 report)
    Normal report (median of 24 earlier)
    543K
    Typical spread (median absolute deviation)
    72K
    How far from its usual level
    +3.5
    Same report last year
    130K
    History used
    608 days
    2025-04-15: 130K2025-04-30: 137K2025-05-15: 198K2025-05-30: 212K2025-06-13: 241K2025-06-30: 536K2025-07-15: 552K2025-07-31: 615K2025-08-15: 585K2025-08-29: 549K2025-09-15: 566K2025-09-30: 615K2025-10-15: 561K2025-10-31: 491K2025-11-14: 482K2025-11-28: 484K2025-12-15: 437K2025-12-31: 530K2026-01-15: 532K2026-01-30: 615K2026-02-13: 635K2026-02-27: 641K2026-03-13: 669K2026-03-31: 653K2026-04-15: 915K
    the 15 Apr 2026 report24 earlier reportsnormal: 543K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  13. 25 Oct 2025Short interest and volume change

    had 561K shares sold short in the 15 Oct 2025 report, 16× the same report last year.

    Same report last year: 34K; its normal report is 115K.

    See the evidence
    This period
    561K (the 15 Oct 2025 report)
    Normal report (median of 24 earlier)
    115K
    Typical spread (median absolute deviation)
    81K
    How far from its usual level
    +3.7
    Same report last year
    34K
    History used
    426 days
    2024-10-15: 34K2024-10-31: 20K2024-11-15: 33K2024-11-29: 38K2024-12-13: 61K2024-12-31: 100K2025-01-15: 80K2025-01-31: 82K2025-02-14: 74K2025-02-28: 77K2025-03-14: 85K2025-03-31: 93K2025-04-15: 130K2025-04-30: 137K2025-05-15: 198K2025-05-30: 212K2025-06-13: 241K2025-06-30: 536K2025-07-15: 552K2025-07-31: 615K2025-08-15: 585K2025-08-29: 549K2025-09-15: 566K2025-09-30: 615K2025-10-15: 561K
    the 15 Oct 2025 report24 earlier reportsnormal: 115K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  14. 10 Oct 2025Short interest and volume change

    had 615K shares sold short in the 30 Sep 2025 report, 47× the same report last year.

    Same report last year: 13K; its normal report is 96K.

    See the evidence
    This period
    615K (the 30 Sep 2025 report)
    Normal report (median of 24 earlier)
    96K
    Typical spread (median absolute deviation)
    63K
    How far from its usual level
    +5.6
    Same report last year
    13K
    History used
    411 days
    2024-09-30: 13K2024-10-15: 34K2024-10-31: 20K2024-11-15: 33K2024-11-29: 38K2024-12-13: 61K2024-12-31: 100K2025-01-15: 80K2025-01-31: 82K2025-02-14: 74K2025-02-28: 77K2025-03-14: 85K2025-03-31: 93K2025-04-15: 130K2025-04-30: 137K2025-05-15: 198K2025-05-30: 212K2025-06-13: 241K2025-06-30: 536K2025-07-15: 552K2025-07-31: 615K2025-08-15: 585K2025-08-29: 549K2025-09-15: 566K2025-09-30: 615K
    the 30 Sep 2025 report24 earlier reportsnormal: 96K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  15. 25 Sep 2025Short interest and volume change

    had 566K shares sold short in the 15 Sep 2025 report, 46× the same report last year.

    Same report last year: 12K; its normal report is 89K.

    See the evidence
    This period
    566K (the 15 Sep 2025 report)
    Normal report (median of 24 earlier)
    89K
    Typical spread (median absolute deviation)
    55K
    How far from its usual level
    +5.8
    Same report last year
    12K
    History used
    396 days
    2024-09-13: 12K2024-09-30: 13K2024-10-15: 34K2024-10-31: 20K2024-11-15: 33K2024-11-29: 38K2024-12-13: 61K2024-12-31: 100K2025-01-15: 80K2025-01-31: 82K2025-02-14: 74K2025-02-28: 77K2025-03-14: 85K2025-03-31: 93K2025-04-15: 130K2025-04-30: 137K2025-05-15: 198K2025-05-30: 212K2025-06-13: 241K2025-06-30: 536K2025-07-15: 552K2025-07-31: 615K2025-08-15: 585K2025-08-29: 549K2025-09-15: 566K
    the 15 Sep 2025 report24 earlier reportsnormal: 89K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  16. 11 Sep 2025Short interest and volume change

    had 549K shares sold short in the 29 Aug 2025 report, 73× the same report last year.

    Same report last year: 7,561; its normal report is 83K.

    See the evidence
    This period
    549K (the 29 Aug 2025 report)
    Normal report (median of 24 earlier)
    83K
    Typical spread (median absolute deviation)
    52K
    How far from its usual level
    +6.1
    Same report last year
    7,561
    History used
    379 days
    2024-08-30: 7,5612024-09-13: 12K2024-09-30: 13K2024-10-15: 34K2024-10-31: 20K2024-11-15: 33K2024-11-29: 38K2024-12-13: 61K2024-12-31: 100K2025-01-15: 80K2025-01-31: 82K2025-02-14: 74K2025-02-28: 77K2025-03-14: 85K2025-03-31: 93K2025-04-15: 130K2025-04-30: 137K2025-05-15: 198K2025-05-30: 212K2025-06-13: 241K2025-06-30: 536K2025-07-15: 552K2025-07-31: 615K2025-08-15: 585K2025-08-29: 549K
    the 29 Aug 2025 report24 earlier reportsnormal: 83K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  17. 27 Aug 2025Short interest and volume change

    had 585K shares sold short in the 15 Aug 2025 report, 136× the same report last year.

    Same report last year: 4,290; its normal report is 81K.

    See the evidence
    This period
    585K (the 15 Aug 2025 report)
    Normal report (median of 24 earlier)
    81K
    Typical spread (median absolute deviation)
    53K
    How far from its usual level
    +6.5
    Same report last year
    4,290
    History used
    365 days
    2024-08-15: 4,2902024-08-30: 7,5612024-09-13: 12K2024-09-30: 13K2024-10-15: 34K2024-10-31: 20K2024-11-15: 33K2024-11-29: 38K2024-12-13: 61K2024-12-31: 100K2025-01-15: 80K2025-01-31: 82K2025-02-14: 74K2025-02-28: 77K2025-03-14: 85K2025-03-31: 93K2025-04-15: 130K2025-04-30: 137K2025-05-15: 198K2025-05-30: 212K2025-06-13: 241K2025-06-30: 536K2025-07-15: 552K2025-07-31: 615K2025-08-15: 585K
    the 15 Aug 2025 report24 earlier reportsnormal: 81K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  18. 25 Jul 2025Filings record

    Registered new securities for sale (S-1)

  19. 7 Jul 2025Filings record

    Private placement of securities (Form D)

  20. 1 Jul 2025Insiders record

    BIOS Fund II, LP (director) and 9 other(s) bought 71,428 shares of ACTU [same transaction as an earlier filing] (dated 30 Jun 2025)

  21. 1 Jul 2025Insiders record

    BIOS Actuate Co-Invest I, LP (director) and 9 other(s) bought 71,428 shares of ACTU ($499,996) (dated 30 Jun 2025)

  22. 1 Jul 2025Insiders record

    Bios Equity COF, LP (director) and 3 other(s) bought 71,428 shares of ACTU [same transaction as an earlier filing] (dated 30 Jun 2025)

  23. 10 Apr 2025Filings record

    Private placement of securities (Form D)

  24. 28 Mar 2025Filings record

    Registered new securities for sale (S-1)

  25. 19 Aug 2024Filings record

    Changed its auditor

  26. 15 Aug 2024Insiders record

    BP Directors, LP (director) and 2 other(s) bought 500,000 shares of ACTU [same transaction as an earlier filing] (dated 14 Aug 2024)

  27. 15 Aug 2024Insiders record

    BIOS Fund II QP, LP (director) and 9 other(s) bought 500,000 shares of ACTU ($4.0M) (dated 14 Aug 2024)

  28. 15 Aug 2024Insiders record

    BIOS Equity Partners III, LP (director) and 9 other(s) bought 500,000 shares of ACTU [same transaction as an earlier filing] (dated 14 Aug 2024)

  29. 14 Aug 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  30. 14 Aug 2024Filings record

    Director or officer change

  31. 23 Jul 2024Filings record

    Registered new securities for sale (S-1)

  32. 19 Jul 2024Filings record

    Registered new securities for sale (S-1)

  33. 16 Jul 2024Filings record

    Registered new securities for sale (S-1)

  34. 21 Jun 2024Filings record

    Registered new securities for sale (S-1)

  35. 11 Jun 2024Filings record

    Registered new securities for sale (S-1)

  36. 24 May 2024Filings record

    Registered new securities for sale (S-1)

  37. 6 Mar 2024Filings record

    Private placement of securities (Form D)

  38. 19 Oct 2022Filings record

    Private placement of securities (Form D)

  39. 10 Dec 2020Filings record

    Private placement of securities (Form D)

  40. 15 Oct 2019Filings record

    Private placement of securities (Form D)

Showing the newest 40 of 44 entries; narrow the window or the kind of data to see older ones.

Not listed: 31 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001652935
Ticker
ACTU
Domain
actuatetherapeutics.com
Hq location
TX|FORT WORTH|76107 (1 unverified)
Name
actuate_ex2101.htm, Actuate Therapeutics, Inc., EX-21.1
  • SEC Form 13F institutional holdings81 data points30 Sep 2024 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)49 records2 Feb 2017 to 13 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)150 data points31 Dec 2022 to 13 Nov 2026
  • SEC Form 4 insider transactions15 records, 20 data points14 Aug 2024 to 29 Oct 2026
  • FINRA short interest (twice monthly)161 data points15 Aug 2024 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)1144 data points13 Aug 2024 to 20 Nov 2026